A new strategy in drug design of chinese medicine: Theory, method and techniques

Hong-jun Yang; Dan Shen; Hai-yu Xu; Peng Lu

doi:10.1007/s11655-012-1270-x

Your Location：

Home >

Browse articles >

A new strategy in drug design of chinese medicine: Theory, method and techniques

OriginalPaper | Updated：2021-08-27

- A new strategy in drug design of chinese medicine: Theory, method and techniques
- A new strategy in drug design of chinese medicine: Theory, method and techniques
- 中国结合医学杂志（英文版） 2012年18卷第11期页码：803-806
- Affiliations：
  
  1. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences,Beijing,China
  2. Institute of Automation, Chinese Academy of Sciences,Beijing,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-012-1270-x
  中图分类号：
- 纸质出版日期：2012，
  
  网络出版日期：2012-10-20，
Scan for full text
Yang, Hj., Shen, D., Xu, Hy. et al. A new strategy in drug design of chinese medicine: Theory, method and techniques., Chin. J. Integr. Med. 18, 803–806 (2012). https://doi.org/10.1007/s11655-012-1270-x

Hong-jun Yang, Dan Shen, Hai-yu Xu, et al. A new strategy in drug design of chinese medicine: Theory, method and techniques[J]. Chinese Journal of Integrative Medicine, 2012,18(11):803-806.
Yang, Hj., Shen, D., Xu, Hy. et al. A new strategy in drug design of chinese medicine: Theory, method and techniques., Chin. J. Integr. Med. 18, 803–806 (2012). https://doi.org/10.1007/s11655-012-1270-x DOI：

Hong-jun Yang, Dan Shen, Hai-yu Xu, et al. A new strategy in drug design of chinese medicine: Theory, method and techniques[J]. Chinese Journal of Integrative Medicine, 2012,18(11):803-806. DOI： 10.1007/s11655-012-1270-x.

摘要

The research and development (R&D) process of Chinese medicine

with one notable feature

clinical application based

is significantly different from which of chemical and biological medicine

from laboratory research to clinics. Besides

compound prescription is another character. Therefore

according to different R&D theories between Chinese and Western medicine

we put forward a new strategy in drug design of Chinese medicine

which focuses on “combination-activity relationship (CAR)”

taking prescription discovery

component identification and formula optimization as three key points to identify the drugs of high efficacy and low toxicity. The method of drug design of Chinese medicine includes: new prescription discovery based on clinical data and literature information

component identification based on computing and experimental research

as well as formula optimization based on system modeling. This paper puts forward the concept

research framework and techniques of drug design of Chinese medicine

which embodies the R&D model of Chinese medicine

hoping to support the drug design of Chinese medicine theoretically and technologically.

Abstract

The research and development (R&D) process of Chinese medicine

with one notable feature

clinical application based

is significantly different from which of chemical and biological medicine

from laboratory research to clinics. Besides

compound prescription is another character. Therefore

according to different R&D theories between Chinese and Western medicine

we put forward a new strategy in drug design of Chinese medicine

which focuses on “combination-activity relationship (CAR)”

taking prescription discovery

component identification based on computing and experimental research

as well as formula optimization based on system modeling. This paper puts forward the concept

research framework and techniques of drug design of Chinese medicine

which embodies the R&D model of Chinese medicine

hoping to support the drug design of Chinese medicine theoretically and technologically.

关键词

drug design of Chinese medicinecombination-activity relationshipprescription discoverycomponent identificationformula optimizationsystem modeling

Keywords

drug design of Chinese medicinecombination-activity relationshipprescription discoverycomponent identificationformula optimizationsystem modeling

references

Wu JA, Ji RY. Application of QSAR in drug design. Foreign Med Sci·Pharm Sect (Chin) 1989;16(1):8–16.

Xu HY, Tang SH, Chen JX, Li DF, Chen C, Yang HJ, et al. Thinking and strategy on combination-activity relationship (CAR) of Chinese medicine based on metabonomics. World Sci Technol-Modern Chin Med (Chin) 2011;13(1):30–35.

Yang HJ, Chen JX, Tang SH, Li ZK, Zhen YS, Huang LQ, et al. New drug R&D of traditional Chinese medicine—role of data mining approaches. J Biol System 2009;17:329–347.

Tang SH, Chen JX, Li G, Wu HW, Chen C, Zhang N, et al. Research on component law of Chinese patent medicine for anti-influenza and development of new recipes for antiinfluenza by unsupervised data mining methods. J Tradit Chin Med 2010;30:288–293.

Lu P, Li J, Tang SH, Chen JX, Zuo XH, Liu X, et al. Development and application of traditional Chinese medicine inheritance support system. Chin J Experim Tradit Med Formul (Chin) 2009;18(9):1–4.

Chen C, Chen JX, Wu HW, Tang SH, Li G, Yi JQ, et al. Identification of key constituents in volatile oil of Ligusticum Chuanxiong based on data mining approaches. Pharmaceut Biol 2011;49:445–455.

Xu HY, Huang LQ, Lu P, Yang HJ. Modernization research thoughts of Chinese medicine based on in vivo ADME process and network pharmacology. China J Chin Mater Med (Chin) 2012;37:142–145.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

暂无数据